Dermata Therapeutics (DRMAW) Q2 2026 Earnings

May 13Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-4.5
-3.16
-1.82
-0.48

Details

Expected EPS
-0.53
Actual EPS
-0.48
Surprise EPS
0.05
Surprise Percent
+9.43%

Description

⁨Dermata Therapeutics⁩ (⁦DRMAW⁩) has reported earnings of ⁦-0.48⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts